Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis

Gut

Volumn 45, Issue 1, 1999, Pages 117-121

  Gadano, A ^a   Moreau, R ^a   Heller, J ^a   Chagneau, C ^a   Vachiery F ^a   Trombino, C ^a   Elman, A ^a   Denie C ^a   Valla, D ^a   Lebrec, D ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Antinatriuretic hormones; Cirrhosis; Haemodynamics; Kidney; O2 consumption; Sodium retention

Indexed keywords

ALDOSTERONE; NATRIURETIC FACTOR; NEUROHORMONE; NORADRENALIN; RENIN; SODIUM;

ADULT; ARTICLE; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY METABOLISM; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SODIUM EXCRETION; SODIUM RETENTION;

EID: 0033006914     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.1.117     Document Type: Article

References (28)

1. 1 Arroyo V, Ginès R Mechanism of sodium retention and ascires formation in cirrhosis. J Hepatol 1993;17(suppl 2):S24-8.
2. 2 Wong F, Blendis L. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor. Semin Liver Dis 1994;14:59-70.
3. 3 Gentillini P, La Villa G, Romanelli RG, et al. Pathogenesis and treatment of ascites in hepatic cirrhosis. Cardiology 1994;84(suppl 2):68-79.
4. 4 Wood LJ, Massie D, McLean AJ, et al. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. Hepatology 1988;8:831-6.
5. 5 Moreau R, Lebrec D. Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis. Introduction to novel approaches to the treatment of sodium retention. J Hepatol 1998;28:1064-9.
6. 6 Silva P. Renal fuel utilization, energy requirements, and function. Kidney Int 1987;32(suppl 22):9-14.
7. 7 Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophagus varices. Br J Surg 1973;60:646-9.
8. 8 Roulot D, Moreau R, Gaudin C, et al. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology 1992; 102:1309-18.
9. 9 Brenard R, Moreau R, Pussard E, et al. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in cirrhotic patients. J Hepatol 1992;14:347-56.
10. 10 Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135-44.
11. 11 Gadano A, Moreau R, Vachiery F, et al. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. J Hepatol 1997;26:1229-34.
12. 12 Moreau R, Lee SS, Soupison T, et al. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol 1988;7:98-105.
13. 13 Moreau R, Gaudin C, Hadengue A, et al. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. Nephron 1993;65:359-63.
14. 14 Hjemdahl P. Catecholamine measurements by high-performance liquid chromatography. Am J Physiol 1984; 247:E13-20.
15. 15 Moore K. The hepatorenal syndrome. Clin Sci 1997;92: 433-43.
16. 16 Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448-60.
17. 17 Arroyo V, Bosch J, Mauri M, et al. Renin aldosterone and renal hemodynamics in cirrhosis with ascites. Eur J Clin Invest 1979;9:69-73.
18. 18 Wilkinson SP, Smith IK, Williams R. Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis. Hypertension 1979;1: 125-9.
19. 19 Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982;307:1552-7.
20. 20 Bernardi M, Santini C, Trevisiani F, et al. Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology 1983;3: 56-64.
21. 21 Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
22. 22 Bernardi M, Trevisani F, Gasbarrini A, et al. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system. Semin Liver Dis 1994;14:23-34.
23. 23 Garg LC. Actions of adrenergic and cholinergic drugs on renal tubular cells. Pharmacol Rev 1992;44:81-102.
24. 24 Cogan MD. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990;15:451-8.
25. 25 Crabbe J. Mechanism of action of aldosterone. In: deGroot LJ, ed. Endocrinology. Philadelphia: WB Saunders, 1989: 1572-81.
26. 26 Gerbés AL. The role of atrial natriuretic peptide (ANP) in chronic liver disease. Pharmacol Ther 1993;58:381-90.
27. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994;8: 436-9.
28. 28 DiBona GF. Renal neural activity in hepatorenal syndrome. Kidney Int 1984;25:841-53.